This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Policy Statement

US Preventive Services Task Force

JAMA. 1993;270(3):369-370.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SUMMARY OF RECOMMENDATION

There is insufficient evidence of clinical effectiveness to recommend for or against home uterine activity monitoring (HUAM) as a screening test for preterm labor in high-risk pregnancies (pregnancies with risk factors for preterm labor). According to the US Preventive Services Task Force (USPSTF) coding system (Tables 1 and 2), this represents a "C" recommendation. Randomized, controlled trials (grade I evidence) report improved clinical neonatal outcomes for high-risk women who receive HUAM. However, the designs of most studies do not permit clear conclusions about whether the results were due to HUAM or to the intensive nursing contacts that accompanied HUAM.

There have been no controlled trials of HUAM in normal pregnancies (pregnancies with no risk factors for preterm labor). In view of the cost of HUAM and the poor evidence that it is efficacious in high-risk pregnancies, the USPSTF recommends against the use of HUAM in normal pregnancy. . . . [Full Text PDF of this Article]

Footnotes
Reprint requests to the Office of Disease Prevention and Health Promotion, US Public Health Service, 330 C St SW, Room 2132, Switzer Bldg, Washington, DC 20201 (Steven H. Woolf, MD, MPH).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?